Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma

Conditions:   Hemangioma;   Kaposiform Hemangioendothelioma Interventions:   Drug: Sirolimus(0.8mg/m2);   Drug: Sirolimus(0.7mg/m2) Sponsor:   Children's Hospital of Fudan University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials